BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36179687)

  • 21. Clinical and genomic features of Chinese lung cancer patients with germline mutations.
    Peng W; Li B; Li J; Chang L; Bai J; Yi Y; Chen R; Zhang Y; Chen C; Pu X; Jiang M; Li J; Zhong R; Xu F; Chen B; Xu L; Wang N; Huan J; Dai P; Guan Y; Yang L; Xia X; Yi X; Wang J; Yu F; Wu L
    Nat Commun; 2022 Mar; 13(1):1268. PubMed ID: 35273153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germline mutations in young non-smoking women with lung adenocarcinoma.
    Donner I; Katainen R; Sipilä LJ; Aavikko M; Pukkala E; Aaltonen LA
    Lung Cancer; 2018 Aug; 122():76-82. PubMed ID: 30032850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer.
    Chao A; Chang TC; Lapke N; Jung SM; Chi P; Chen CH; Yang LY; Lin CT; Huang HJ; Chou HH; Liou JD; Chen SJ; Wang TH; Lai CH
    Oncotarget; 2016 Dec; 7(51):85529-85541. PubMed ID: 27907908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms and rare variants identified by next-generation sequencing confer risk for lung cancer in han Chinese population.
    Li X; Liu J; Wang K; Zhou J; Zhang H; Zhang M; Shi Y
    Pathol Res Pract; 2020 Apr; 216(4):152873. PubMed ID: 32107087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Recurrent Variants in
    Jiang Y; Tian T; Yu C; Zhou W; Yang J; Wang Y; Wen Y; Chen J; Dai J; Jin G; Ma H; Shen H; Hu Z
    Biomed Res Int; 2020; 2020():6739823. PubMed ID: 32879886
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients.
    Kim YC; Zhao L; Zhang H; Huang Y; Cui J; Xiao F; Downs B; Wang SM
    Oncotarget; 2016 Feb; 7(8):9600-12. PubMed ID: 26848529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a rare germline NBN gene mutation by whole exome sequencing in a lung-cancer survivor from a large family with various types of cancer.
    Marafie MJ; Dashti M; Al-Mulla F
    Fam Cancer; 2017 Jul; 16(3):389-394. PubMed ID: 27844240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients.
    Renieri A; Mencarelli MA; Cetta F; Baldassarri M; Mari F; Furini S; Piu P; Ariani F; Dragani TA; Frullanti E
    Lung Cancer; 2014 Aug; 85(2):168-74. PubMed ID: 24954872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas.
    Yamamoto H; Higasa K; Sakaguchi M; Shien K; Soh J; Ichimura K; Furukawa M; Hashida S; Tsukuda K; Takigawa N; Matsuo K; Kiura K; Miyoshi S; Matsuda F; Toyooka S
    J Natl Cancer Inst; 2014 Jan; 106(1):djt338. PubMed ID: 24317180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls.
    Li A; Xie R; Zhi Q; Deng Y; Wu Y; Li W; Yang L; Jiao Z; Luo J; Zi Y; Sun G; Zhang J; Shi Y; Liu J
    Gynecol Oncol; 2018 Oct; 151(1):145-152. PubMed ID: 30078507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung cancer risk and genetic variants in East Asians: a meta-analysis.
    Zhang Q; Jin H; Wang L; Xin B; Zhang J; Zhou Y; Sheng S
    Tumour Biol; 2014 Jun; 35(6):5173-9. PubMed ID: 24515656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent germline mutation in the BRCA2 gene in esophageal squamous cell carcinoma patients from a low-risk Chinese population.
    Zhong L; Zhu ZZ; Shen Y; Sun G; Zhao X; Zhang S; Yin X; Zhu J; Xu Z; Zhu G
    Asian Pac J Cancer Prev; 2011; 12(7):1771-6. PubMed ID: 22126563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common Germline Mutations in a Patient With Multiple Primary Lung Cancers.
    Cytryn S; Moreira A; Chachoua A; Sabari J
    Clin Lung Cancer; 2020 May; 21(3):e212-e215. PubMed ID: 32127285
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia.
    Yang XR; Devi BCR; Sung H; Guida J; Mucaki EJ; Xiao Y; Best A; Garland L; Xie Y; Hu N; Rodriguez-Herrera M; Wang C; Jones K; Luo W; Hicks B; Tang TS; Moitra K; Rogan PK; Dean M
    Breast Cancer Res Treat; 2017 Oct; 165(3):687-697. PubMed ID: 28664506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women.
    Zeng C; Guo X; Wen W; Shi J; Long J; Cai Q; Shu XO; Xiang Y; Zheng W
    Breast Cancer Res Treat; 2020 Jun; 181(2):465-473. PubMed ID: 32318955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients.
    Ohashi R; Umezu H; Sato A; Abé T; Kondo S; Daigo K; Sato S; Hara N; Miyashita A; Ikeuchi T; Motoyama T; Kishi M; Nagaoka T; Horiuchi K; Shiga A; Okuda S; Sekiya T; Ohtsubo A; Ichikawa K; Kagamu H; Kikuchi T; Watanabe S; Tanuma JI; Schraml P; Hamakubo T; Tsuchida M; Ajioka Y
    Cells; 2020 Nov; 9(11):. PubMed ID: 33153169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.
    Zhong X; Dong Z; Dong H; Li J; Peng Z; Deng L; Zhu X; Sun Y; Lu X; Shen F; Su X; Zhang L; Gu Y; Zheng H
    PLoS One; 2016; 11(6):e0156789. PubMed ID: 27257965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A de novo germline mutation of APC for inheritable colon cancer in a Chinese family using multigene next generation sequencing.
    Zhang Y; Lu G; Hu Q; Wang X; Li C; Mao Y; Cui M
    Biochem Biophys Res Commun; 2014 May; 447(3):503-7. PubMed ID: 24735542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1).
    Sorscher S; Ansley K; Delaney SD; Ramkissoon S
    Breast Cancer Res Treat; 2020 Apr; 180(2):511-514. PubMed ID: 32040686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series.
    Sukumar J; Kassem M; Agnese D; Pilarski R; Ramaswamy B; Sweet K; Sardesai S
    Breast Cancer Res Treat; 2021 Apr; 186(2):569-575. PubMed ID: 33507482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.